TransMedics Group, Inc. SEC filings TMDX
TransMedics Group, Inc. has 630 filings in SEC EDGAR's recent list, going back to Oct 19, 2018. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 10, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 27, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 12, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 17, 2020 | Dec 28, 2019 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- TMDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Andover, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1756262
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.